February 17, 2023 Comments Off on New patent for Amgen Inc drug LUMAKRAS Posted in: Patent Added Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWat…
February 17, 2023 Comments Off on New patent for Vanda Pharms drug HETLIOZ Posted in: Patent Added Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are twenty-one…
The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPate…